Skip to main content
. 2024 Oct 29;14(21):2406. doi: 10.3390/diagnostics14212406

Figure 2.

Figure 2

Predictors of EHRI in patients receiving rHuEPO (Legend: CI—confidence interval; BMI—body mass index; PAI-1—plasminogen activator inhibitor-1; L-FABP—L-type fatty acid binding protein).